Sertraline

Learn what this care may do. See what research says. Then check where to get care. A place may not be taking new patients.

Published Sep 21, 2026Revision 5 · EveryOptionen-US

identity

Sertraline (brand name ZOLOFT) is a prescription medicine. Its U.S. product labeling lists obsessive-compulsive disorder (OCD) among the conditions it is indicated to treat.

DailyMed sertraline (Zoloft) label · checked Sep 18, 2026

Relationship: supports

Scope: country:US

Pointer: /sections/1

Open source

why-linked

EveryOption includes sertraline for OCD because the DailyMed ZOLOFT label’s Indications and Usage section names OCD as a labeled indication. That label statement was checked against this source. A clinical evidence assessment of how well sertraline works for OCD has not yet been published here.

DailyMed sertraline (Zoloft) label · checked Sep 18, 2026

Relationship: supports

Scope: country:US

Pointer: /sections/1

Open source

indication-quote

• Obsessive-compulsive disorder (OCD)

DailyMed sertraline (Zoloft) label · checked Sep 18, 2026

Relationship: supports

Scope: country:US

Pointer: /sections/1

Open source

scope

This page explains why the option appears and what the cited label supports. It does not set dosing, compare treatments, or report availability. Access information is not shown here.

DailyMed sertraline (Zoloft) label · checked Sep 18, 2026

Relationship: supports

Scope: country:US

Pointer: /sections/1

Open source

provenance

Cited source: DailyMed (U.S. National Library of Medicine) structured product label for ZOLOFT (sertraline hydrochloride), SET ID fda754f6-d0f3-4dce-a17a-927d64f912f7, version 7, Indications and Usage. Hosting on DailyMed is not a license to republish the full label.

DailyMed sertraline (Zoloft) label · checked Sep 18, 2026

Relationship: supports

Scope: country:US

Pointer: /sections/1

Open source

published scope

EveryOption currently publishes Sertraline research for bulimia nervosa, major depressive disorder, obsessive-compulsive disorder, and panic disorder. Each exact Need page states its source and limits. This is not a complete list of uses.

PubMed Central open-access full text · checked Sep 21, 2026

Relationship: supports published treatment scope

Scope: global

Pointer: /document/passage

Open source
DailyMed sertraline (Zoloft) label · checked Sep 20, 2026

Relationship: supports published treatment scope

Scope: country:US

Pointer: /sections/2

Supporting passage: The effectiveness of ZOLOFT in the treatment of PD was demonstrated in three double‑blind, placebo‑controlled studies (Studies PD-1, PD-2, and PD‑3) of adult outpatients who had a primary diagnosis of PD (DSM‑III‑R), with or without agoraphobia.

Open source
DailyMed sertraline (Zoloft) label · checked Sep 18, 2026

Relationship: supports published treatment scope

Scope: country:US

Pointer: /sections/1

Open source
DailyMed sertraline (Zoloft) label · checked Sep 20, 2026

Relationship: supports published treatment scope

Scope: country:US

Pointer: /sections/1

Supporting passage: The efficacy of ZOLOFT as a treatment for MDD was established in two randomized, double-blind, placebo-controlled studies and one double-blind, randomized-withdrawal study following an open label study in adult (ages 18 to 65) outpatients who met the Diagnostic and Statistical Manual of Mental Disorders (DSM-III) criteria for MDD (studies MDD-1 and MDD-2).

Open source

Published Need relationships

Select an exact Need to inspect its scoped research. Published conclusions appear first; uses without one follow under Not reviewed. This order is not a personal recommendation.

4 published uses

Research we have checked

  • Major Depressive Disorder

    DailyMed sertraline (Zoloft) label · checked Sep 20, 2026

    Relationship: label-reported clinical studies for the Need

    Scope: country:US

    Pointer: /sections/1

    Supporting passage: The efficacy of ZOLOFT as a treatment for MDD was established in two randomized, double-blind, placebo-controlled studies and one double-blind, randomized-withdrawal study following an open label study in adult (ages 18 to 65) outpatients who met the Diagnostic and Statistical Manual of Mental Disorders (DSM-III) criteria for MDD (studies MDD-1 and MDD-2).

    Open source

    Research suggests benefit in this exact scope

    Published Sep 20, 2026 · revision 1

    Read exact answer

  • Panic Disorder

    DailyMed sertraline (Zoloft) label · checked Sep 20, 2026

    Relationship: label-reported clinical studies for the Need

    Scope: country:US

    Pointer: /sections/2

    Supporting passage: The effectiveness of ZOLOFT in the treatment of PD was demonstrated in three double‑blind, placebo‑controlled studies (Studies PD-1, PD-2, and PD‑3) of adult outpatients who had a primary diagnosis of PD (DSM‑III‑R), with or without agoraphobia.

    Open source

    Research suggests benefit in this exact scope

    Published Sep 20, 2026 · revision 1

    Read exact answer

  • Bulimia Nervosa

    PubMed Central open-access full text · checked Sep 21, 2026

    Relationship: small trial of sertraline for bulimia nervosa

    Scope: global

    Pointer: /document/passage

    Open source

    Promising, with important evidence limits

    Published Sep 21, 2026 · revision 1

    Read exact answer

Not reviewed

  • Obsessive-Compulsive Disorder

    DailyMed sertraline (Zoloft) label · checked Sep 18, 2026

    Relationship: labeled indication

    Scope: country:US

    Pointer: /sections/1

    Open source

    Not reviewed

    No current published assessment exists for this exact Treatment and Need. This does not establish benefit or no benefit.

    Read exact answer

Next: check access

Research and local availability are different facts. Add a place to see known, source-backed access options for Sertraline.

Find access

See something wrong? Tell us. Your note is private. We check sources before we change this page.